Kieran Daly discusses how adherence programs can improve patient outcomes, support specialty pharmacy performance, and reduce healthcare costs. Tracking when a prescription ships or a refill is ...
Payers and providers now expect RWE to complement trial efficacy by demonstrating effectiveness, utilization impact, and ROI ...
Formulary exclusions have expanded from ~30 to ~1,400 in a decade, reflecting insurer responses to crowded classes and accelerating the migration of certain brands toward cash channels. Retail step ...
Formulary positioning and benefit design frequently determine utilization, as weak placement or reimbursement dynamics can ...
Integrated direct-to-patient models use AI-enabled eBenefits/eVerification plus real-time claims adjudication to surface ...
Claude Code is expected to standardize and accelerate software and AI development while improving access to data and ...
Supreme Court inaction leaves intact lower-court rulings rejecting takings and compelled-speech theories against “fair price” designations in Medicare price negotiation. Courts emphasized ...
National polling indicates 54% of rural adults face at least one healthcare access barrier, underscoring that “access” is multidimensional and differs from coverage-centric system design. High cost ...
In this week's Pharma Pulse, the Trump administration expands TrumpRx to over 600 generics, the Supreme Court clears the way for long-term Medicare drug price negotiations, Eli Lilly moves deeper into ...
BIOSECURE is catalyzing structural sourcing and manufacturing shifts, prompting reassessment of legacy partnerships and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results